The Comparison of Efficacy of Behavioral Approaches for Treatment of Insomnia study aims to compare the effectiveness of four different therapies for insomnia: CBT, FOA, combined CBT and FOA, and Sleep Hygiene.
Patients will undergo either Cognitive Behavioral Therapy (CBT), Focus of Attention (FOA), combined CBT and FOA or Sleep Hygiene (acting as a control group) during 6 weekly sessions of one hour. Assigned therapy will be randomized. At the end of the treatment period, participants will then report any improvements in their insomnia as well as 3, 6 and 12 months later. All participants must meet the DSM-5 diagnostic criteria for insomnia.
- Male and female outpatients aged 18 or older, up to 72 years.
- Has an Insomnia Severity Index greater than or equal to 10
- Meets the diagnostic criteria for Insomnia Disorder per DSM-5
- Is willing and able to sign an informed consent form
- Does not plan on relocating at any time during the next 12 weeks
- Pregnant or lactating women
- Individuals who work night shifts and individuals who took naps 3 or more times per week in the month prior to the start of study
- Drinks more than 5 servings of caffeinated beverages per day
- Is currently enrolled in another insomnia study
- Is unable to complete study questionnaires and psychological exams
- Is unable to comply with the study’s obligations
- Has severe anxiety (BAI >= 36) or depression (BDI >=29)
- Has a history of epilepsy, seizures or dementia
- Has a severe, unstable or chronically progressing medical condition
- Has suffered a serious head injury or stroke in the past year
- Suffers from current alcohol addiction or dependence – must be sober for more than 90 days
- Has any other neurological disorders such as multiple sclerosis or Parkinson’s disease
- Has an untreated or unstable psychiatric condition that has required hospital admission in the last two years. Those currently taking psychotropic medications are allowed to participate if they have taken a stable dosage in the 2 months before the study and if their medication does not affect the study outcome.
- Takes medications or drugs that may cause insomnia
- Has sleep apnea (AHI score > 15). If participant uses a CPAP device, they are allowed to take part in the study if they fall below the apnea / hypopnea cutoff and use their device throughout the duration of the study.
Puget Sound Psychiatric Center
Bothell, Washington, United States
Sponsors / Collaborators
Pacific Institute of Medical Sciences
Clinical TrialsView All Clinical Trials
Brief Telehealth CBT-I Intervention in the Context of the COVID-19 Pandemic
The Brief Telehealth CBT-I Intervention in the Context of the COVID-19…
Therapist-Directed VS Online Therapy for Insomnia Co-Occurring With Sleep Apnea
The Therapist-Directed VS Online Therapy for Insomnia Co-Occurring With…
Sleep To Reduce Incident Depression Effectively
The Sleep To Reduce Incident Depression Effectively
Partial Reinforcement II: Three Approaches to Maintenance Therapy for Chronic Insomnia
The Partial Reinforcement II: Three Approaches to Maintenance Therapy for…
Reducing Cannabis Use for Sleep Among Adults Using Medical Cannabis
The Reducing Cannabis Use for Sleep Among Adults Using Medical Cannabis…
The EMS Sleep Health Study: A Randomized Controlled Trial
The EMS Sleep Health Study: A Randomized Controlled Trial aims to…
Internet Cognitive Behavioral Therapy for Insomnia to Prevent Cardiovascular Disease
The Internet Cognitive Behavioral Therapy for Insomnia to Prevent…